Back to Search Start Over

Deal snapshot: Ikena Oncology Merges with Inmagene Biopharmaceuticals

Source :
M & A Navigator. January 3, 2025
Publication Year :
2025

Abstract

MANews-(C)2009-2025 US-based Ikena Oncology, Inc. (NASDAQ: IKNA) has entered into a reverse merger and PIPE transaction with US-based clinical stage company Inmagene Biopharmaceuticals, the company said. In connection with the [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M & A Navigator
Publication Type :
News
Accession number :
edsgcl.822221028